---
title: "DexCom Inc Announces CEO Appointment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/270536037.md"
description: "DexCom Inc announced the appointment of Jacob S. Leach as President and CEO, effective January 1, 2026, following Kevin R. Sayer's resignation. Leach previously served as interim principal executive officer and will also join the board as a director. The change was disclosed in an SEC filing dated December 22, 2025."
datetime: "2025-12-22T21:43:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/270536037.md)
  - [en](https://longbridge.com/en/news/270536037.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/270536037.md)
---

# DexCom Inc Announces CEO Appointment

On December 19, 2025, DexCom Inc announced the appointment of Jacob S. Leach as President and Chief Executive Officer, effective January 1, 2026, following the resignation of Kevin R. Sayer.

**Individual**

Jacob S. Leach

Kevin R. Sayer

**Role**

President and CEO

CEO

**Type of Change**

Appointed

Resigned

**Effective Date**

Jan 1, 2026

Jan 1, 2026

**Reason**

N/A

Medical leave

**Replacement Info**

N/A

Jacob S. Leach

**Background Details**

Interim principal executive officer

N/A

**Board/Committee Role Changes**

Director

Not disclosed

Original SEC Filing: DEXCOM INC \[ DXCM \] - 8-K - Dec. 22, 2025

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [DXCM.US](https://longbridge.com/en/quote/DXCM.US.md)

## Related News & Research

- [Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany | DXCM Stock News](https://longbridge.com/en/news/286763500.md)
- [Are Wall Street Analysts Bullish on DexCom’s Stock?](https://longbridge.com/en/news/286558977.md)
- [BUZZ-Dexcom climbs on plans to revamp board panel](https://longbridge.com/en/news/286583878.md)
- [DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day](https://longbridge.com/en/news/286646080.md)
- [Barclays Sticks to Its Sell Rating for Dexcom (DXCM)](https://longbridge.com/en/news/286694769.md)